Share Name Share Symbol Market Type Share ISIN Share Description
Horizon Discvry LSE:HZD London Ordinary Share GB00BK8FL363 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 268.50p 265.00p 272.00p 268.50p 267.50p 268.50p 1,710 14:00:03
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 24.1 -12.5 -12.1 - 267.35

Horizon Discvry Share Discussion Threads

Showing 876 to 900 of 900 messages
Chat Pages: 36  35  34  33  32  31  30  29  28  27  26  25  Older
DateSubjectAuthorDiscuss
08/8/2017
19:57
Congrats to those brave souls who piled in a few months ago when the share price was dropping like a stone
kestelmill
08/8/2017
18:10
Impressive indeed and I bet more to come.
mirabeau
08/8/2017
14:55
Also more than double the January 1st price of £1.43 -Happy days! Sold one third on the last spike expecting a drop but will be happy if this continues.
cumbrian2
08/8/2017
14:30
Blimey, 40% above the placing price. Gotta admit - I didnt expect this reaction...
phowdo
08/8/2017
14:21
Happy days. If ever there was a case of run your winners, cut your losers, this is it.
mamcw
07/8/2017
10:17
An anecdote - post completion of the Dharmacon deal, HZD will in the top 50 of AIM stocks by market capitalisation. AIM stocks are increasingly being used by wealth planners for the rich as an IHT shelter, particularly by those fearful of a Corbyn government.
mamcw
03/8/2017
11:36
Some determined buying this morning - looks like we could be about to re-test the highs
mamcw
27/7/2017
11:09
HZD make an EBITDA loss but this should turn to profit once Dharmacon is bolted on (thanks to Dharmacon profit)
kestelmill
27/7/2017
10:32
Do they make a profit yet
mj19
21/7/2017
15:50
Who are Dharmacon's key competitors for RNAi products? What's Dharmacon's advantage over them? I think HZD's plan to productise HZD's CRISPr tools for the research market is great. Financially this is also a good move for HZD since they should now become profitable quite quickly on the back of this and that will encourage ii's to buy... ...until Disley's next bold move, because let's be honest, he's going to spend whatever money is available plus a whole lot more (on M&A). HZD have come so far since they floated. The emphasis has been on investing in revenue growth and becoming a major player in gene editing, not on profit. That has not been ideal for short term investors - the share price has not done well - but as a long-term holder I am satisfied they have been creating value and making the right strategic calls.
kestelmill
21/7/2017
10:48
Doubled since following the director buys back in December. I've taken profits and running some for "free". As stratego says there is now integration risk and we've seen Horizon get indigestion before...
phowdo
20/7/2017
23:20
Stratego makes a valid point about execution risk. Also, I am not 100% clear yet on how Dharmacon makes sense as an acquisition, as I don't understand them well enough yet. Market seems to love it though.
kestelmill
20/7/2017
19:32
So HZD now my largest holding and naturally very interested that most holders (as reflected in the share price move) see yesterday's RNS as an extremely positive development. It's always good to have a contrarian view. Which makes the one dissenter Stratego - worthy of further analysis. It seems Stratego joined ADVFN in 2014 but since then has only posted nothing until the comments on this thread in the last couple of days. Which suggests these comments do not come from an experienced investor and perhaps we should not see them as valid. There may be a different reason for these comments on HZD in particular. Am I right? Stratego can you clarify pls?
melody9999
20/7/2017
17:30
They have clearly got the placing away with city institutions. These boys don't generally trade for a quick buck. If we've got serious ii interest then current rise in share price speaks volumes of where they see the company going. A large placing and the share price rises by 25% is great news. Lots of ii's have confidence in this. I'm locking my shares away and will look at them periodically. Personally I expect some further gains and eventually good dividends. Imho, Dyor
xippy
20/7/2017
16:47
yes - they have just bolted on a turnaround situation onto a business that is not profitable and a management team that has zero track record in making profits. it strikes me that the market is ignoring the execution risk and putting too much credit on a positive outcome. It might be great, but that is the upside case rather than the base case which in my view is this: difficult integration, difficult turnaround, and missed profit target at HD means they miss expectations
stratego
20/7/2017
16:35
Stratego, Your main issue with them seems to be that Dharmacon had shrinking revenues and boring siRNA technology. Any issue other than that? They are ticking a lot of boxes for me. -A leader in gene editing products and services -A leader in NGS standards -Massive range of edited cell lines -Strong penetration into research and pharma markets -Rapidly growing revenues and market
kestelmill
20/7/2017
15:34
HZD have been very astute so far. Their management deserve trust over this move. They can obviously see value and rapid US revenue growth ahead whereas they were barely in contention previously.
tonsil
20/7/2017
15:27
you guys are smoking something. A mature dog of a company added onto an immature company = a dog company in most outcomes. The unlikely outcome is a magical turnaround and combined wonderfulness. Short.
stratego
19/7/2017
22:27
StrategoThe value is in the people and a going concern that would take years to put together. The technology can quickly be broadened to HZD's leading edge.
tonsil
19/7/2017
22:19
Bought a business with declining revenue - why all the excitement? SiRna technology is old news. Inexpensive RNA synthesis will negate need for Dharamacon.
stratego
19/7/2017
16:54
A very strong finish to the trading day, with share price at an all time high on a great deal. Will be interested to see any new brokers' notes in the next few days. Patience has been rewarded with this stock. :)
mamcw
19/7/2017
14:30
Worthwhile looking through the investor presentation on the HZD website https://www.horizondiscovery.com/media/investor/analyst-presentation-acquisition-of-dharmacon.pdf Last 3 / 4 slides make particularly interesting reading in terms of explaining transaction rationale and potential market opportunity for HZD.
mamcw
19/7/2017
12:21
Thanks for the insights mamcw
kestelmill
19/7/2017
11:21
I wonder how much GE initially paid for Dharmacon inc.? I reckon GE thought HZD could do a better job of extracting value in this area of biotechnology than they could. This could explain why GE has maintained an indirect interest I wonder if GE took a loss on this sale?
mirabeau
19/7/2017
11:17
mamcw - Excellent analysis! Thank you.
gorilla36
Chat Pages: 36  35  34  33  32  31  30  29  28  27  26  25  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20170819 20:36:37